Catalyst Wire Dossier Catalyst Wire Dossier

Allogeneic natural killer cell therapy

Allogeneic NK cell therapy · Institute of Hematology & Blood Diseases Hospital, China
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Allogeneic natural killer cell therapy, covering 2024-11-06 to 2026-04-09. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Natural Killer Cells in Combination With Atezolizumab in People With Acute Myelogenous Leukemia [Phase 1]

See pricing